ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1636

Pro-Inflammatory HDL and Subclinical Atherosclerosis Are Associated With Altered Expression Of Epigenetic and Oxidative Stress-Related Gene Transcripts In SLE

Brian Skaggs1, Bevra H. Hahn2, Jennifer M. Grossman3, Elaine Lourenco1, Isao Matsuura4, Lori Sahakian5 and Maureen A. McMahon6, 1Medicine/Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 2Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 3Division of Rheumatology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, 4UCLA David Geffen School of Medicine, Los Angeles, CA, 5Division of Rheumatology, Department of Medicine,, UCLA David Geffen School of Medicine, Los Angeles, CA, 6Division of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: atherosclerosis and epigenetics, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus-Human Etiology and Pathogenesis: Genetics and Genomics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Premature atherosclerosis is widely recognized as a significant co-morbid condition of systemic lupus erythematosus (SLE), but exact mechanisms are unknown.  Although traditional cardiovascular risk factors correlate with subclinical atherosclerosis in cohort studies, they are unable to fully account for the increased risk.  Longer SLE duration correlates with higher risk for cross-sectional and longitudinal progression of atherosclerosis, suggesting that chronic inflammation and/or oxidative stress could be SLE-specific factors contributing to accelerated atherosclerosis.  Plasma pro-oxidant, pro-inflammatory HDL (piHDL) is also closely linked to presence and progression of plaque in SLE and can abnormally activate monocytes, the major immune cell type involved in atherosclerosis.  Recent data have linked oxidative stress to epigenetic aberrations in non-autoimmune subjects with atherosclerosis, and we wanted to examine whether these mechanisms could partially explain the risk of premature atherosclerosis in SLE. 

Methods:

Patients were recruited from a pre-existing cohort to study atherosclerosis in SLE.  Carotid ultrasound was performed to determine the presence or absence of subclinical atherosclerosis (plaque).  HDL status was determined by a fluorometric assay examining oxidation of human LDL in the presence of patient HDL.  RNA was isolated from freshly isolated primary monocytes from 51 SLE patients subdivided into three groups: a) plaque+piHDL+ (LPP, n=15), b) plaque-piHDL+ (LPN, n=18), and c) plaque-piHDL- (LNN, n=18).  Whole-genome monocyte expression analysis was performed using Affymetrix Human U133+2.0 chips.  dChip software (Li lab, Harvard) was utilized to determine differentially expressed transcripts between the three groups.  Clustering was performed and graphed using Cluster and TreeView (Eisen lab, UC Berkeley).  Confirmation of significantly altered transcript levels was determined using quantitative PCR.

Results:

Expression of 385 genes was significantly altered between the LPP and LNN groups (fold change ≥1.2 or ≤-1.2, p≤0.05, false discovery rate 6.8%).  The majority of the differentially-expressed genes were downregulated in LPP (vs. LNN).  A large proportion of genes were involved in histone acetylation, DNA methylation, and oxidative stress (14% of the total; <5% expected).  Multiple methyltransferases (MT) were downregulated in LPP subjects, including DNMT1.  The presence of piHDL correlates with lower MT, acetyltransferase, and oxidative stress transcripts, as many of the same transcripts were downregulated in the LPN group (vs. LNN).  Conversely, the antioxidants peroxiredoxin2 (PRDX2) and superoxide dismutase 2 (SOD2) were upregulated in LPN and LPP groups versus LNN.  Unsupervised clustering placed almost all samples into their piHDL/plaque subgroups.

Conclusion:

The presence of piHDL correlates with dysregulation of multiple epigenetic and oxidative stress-related transcripts in circulating monocytes of SLE patients.  Further epigenetic and biochemical experiments will determine the role of lipid and protein oxidation in the initiation of premature atherosclerosis in SLE.


Disclosure:

B. Skaggs,
None;

B. H. Hahn,

Eli Lilly and Company,

5,

Biogen-IDEC,

5,

Astella Pharma ,

5,

Teva Pharmaceutical,

2;

J. M. Grossman,

UCB, Eli Lilly, Medimmune, pfizer- I am doing lupus clinical trials compounds made by these companies that are in phase 2 or 3 studies. I am an investigator in multcenter trials. ,

2;

E. Lourenco,
None;

I. Matsuura,
None;

L. Sahakian,
None;

M. A. McMahon,

GlaxoSmithKline,

8.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pro-inflammatory-hdl-and-subclinical-atherosclerosis-are-associated-with-altered-expression-of-epigenetic-and-oxidative-stress-related-gene-transcripts-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology